Skip to main content
OpenTrials

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,049 public trials 570 recruiting studies
Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Completed

A Study of AT9283 in Patients With Relapsed or Refractory Multiple Myeloma

NCT01145989

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Atlantic Health Sciences Corporation Saint John, New Brunswick, Canada
  • QEII Health Sciences Center Halifax, Nova Scotia, Canada
View Trial Details
Completed

Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma

NCT00305812

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Tom Baker Cancer Centre - Calgary Calgary, Alberta, Canada
  • Cross Cancer Institute at University of Alberta Edmonton, Alberta, Canada
  • British Columbia Cancer Agency - Centre for the Southern Interior Kelowna, British Columbia, Canada
  • Moncton Hospital Moncton, New Brunswick, Canada
View all 14 locations
View Trial Details
Completed

Safety and Efficacy Study of a Triplet Combination of MLN9708, Lenalidomide and Dexamethasone in the Initial Management of Multiple Myeloma (IFM2013-06)

NCT01936532

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • CHRU - Hôpital du Haut Lévêque Bordeaux, France
  • CHRU Dijon Dijon, France
  • Centre hospitalier départemental Vendée La Roche-sur-Yon, France
  • CHRU - Hôpital Claude Huriez Lille, France
View Trial Details
Completed

IXAZOMIB Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma

NCT01850524

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Birmingham, Alabama, United States
  • Chandler, Arizona, United States
  • Tucson, Arizona, United States
  • Little Rock, Arkansas, United States
View all 147 locations
View Trial Details
Completed

SAR650984 (Isatuximab), Lenalidomide, and Dexamethasone in Combination in RRMM Patients

NCT01749969

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Investigational Site Number 840004 San Francisco, California, United States
  • Investigational Site Number 840001 Tampa, Florida, United States
  • Investigational Site Number 840002 St Louis, Missouri, United States
  • Investigational Site Number 840005 New York, United States
View Trial Details

Related conditions